1. Home
  2. PFX vs CVRX Comparison

PFX vs CVRX Comparison

Compare PFX & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFX

PhenixFIN Corporation

N/A

Current Price

$47.09

Market Cap

88.9M

Sector

Finance

ML Signal

N/A

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$3.02

Market Cap

78.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFX
CVRX
Founded
2010
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.9M
78.6M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
PFX
CVRX
Price
$47.09
$3.02
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$10.50
AVG Volume (30 Days)
15.3K
1.6M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
3.57%
N/A
EPS Growth
N/A
23.02
EPS
0.30
N/A
Revenue
N/A
$56,651,000.00
Revenue This Year
N/A
$17.17
Revenue Next Year
N/A
$17.69
P/E Ratio
$156.03
N/A
Revenue Growth
N/A
10.45
52 Week Low
$38.30
$2.20
52 Week High
$56.48
$11.30

Technical Indicators

Market Signals
Indicator
PFX
CVRX
Relative Strength Index (RSI) 44.56 39.14
Support Level $42.03 $2.20
Resistance Level $47.81 $3.33
Average True Range (ATR) 2.02 0.25
MACD -0.36 0.07
Stochastic Oscillator 2.69 42.86

Price Performance

Historical Comparison
PFX
CVRX

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: